Skip to main content
logo
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
34.84
-0.21 (-0.60%)
At close: Apr 2, 2026, 4:00 PM EDT
34.84
0.00 (0.00%)
After-hours: Apr 2, 2026, 4:14 PM EDT

Alkermes Revenue

In the year 2025, Alkermes had annual revenue of $1.48B, down -5.25%. Alkermes had revenue of $384.55M in the quarter ending December 31, 2025, a decrease of -10.57%.

Revenue (ttm)
$1.48B
Revenue Growth
-5.25%
P/S Ratio
3.94
Revenue / Employee
$719,951
Employees
2,050
Market Cap
5.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.48B-81.73M-5.25%
Dec 31, 20241.56B-105.77M-6.36%
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.96M-5.28%
Dec 31, 20211.17B135.00M13.00%
Dec 31, 20201.04B-132.19M-11.29%
Dec 31, 20191.17B76.67M7.01%
Dec 31, 20181.09B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elanco Animal Health4.72B
Dr. Reddy's Laboratories3.85B
Amneal Pharmaceuticals3.02B
Neurocrine Biosciences2.86B
Hims & Hers Health2.35B
Lantheus Holdings1.54B
Prestige Consumer Healthcare1.10B
Supernus Pharmaceuticals718.95M
Revenue Rankings

ALKS News

More News